EQS-News: CompuGroup Medical successfully completes share buyback program
|
EQS-News: CompuGroup Medical SE & Co. KGaA
/ Key word(s): Share Buyback
CompuGroup Medical successfully completes share buyback program
Koblenz - CompuGroup Medical SE & Co. KGaA (CGM) has ended its share buyback program successfully on April 26 shortly before the expiration date. The target of a maximum of 500,000 shares to be acquired was reached last Friday. The volume acquired corresponds to approximately 0.93% of the Company´s share capital. The company announced the start of the program on March 25, 2024 pursuant to Art. 2 para. 1 Commission Delegated Regulation (EU) No 2016/1052 to start on March 26, 2024. The weighted average price per share acquired was EUR 29.26, the total volume of the buyback was EUR 14.6 million. The general partner of CGM had granted a volume of up to EUR 15.5 million for the buyback. CFO Daniela Hommel said: "We are pleased with the successful share buyback. By acquiring own shares we are confirming our confidence in the future of our company and are expanding our options for further strategic development." The shares were purchased exclusively via the Frankfurt Stock Exchange (XETRA trading) by a bank commissioned by CGM. The Company's own shares acquired through the buyback program can be used for any purpose permitted under the authorization granted by the Annual General Meeting on May 19, 2021. Further information on the share buyback program and the upcoming virtual Annual General Meeting on 22 May can be found on the website at https://www.cgm.com/corp_en/company/ir-en.html.
29.04.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
| Language: | English |
| Company: | CompuGroup Medical SE & Co. KGaA |
| Maria Trost 21 | |
| 56070 Koblenz | |
| Germany | |
| Phone: | +49 (0)160 3630362 |
| Fax: | +49 (0)261 8000 3200 |
| E-mail: | investor@cgm.com |
| Internet: | www.cgm.com |
| ISIN: | DE000A288904 |
| WKN: | A28890 |
| Indices: | SDAX, TecDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1891987 |
| End of News | EQS News Service |
|
|
1891987 29.04.2024 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | ||
| Sales1 | 837,26 | 1.025,32 | 1.129,74 | 1.187,66 | 1.153,99 | 1.188,00 | 0,00 | |
| EBITDA1,2 | 197,48 | 213,39 | 216,35 | 229,76 | 218,74 | 0,00 | 0,00 | |
| EBITDA-Margin3 | 23,59 | 20,81 | 19,15 | 19,35 | 18,96 | 0,00 | 0,00 | |
| EBIT1,4 | 121,77 | 102,68 | 104,03 | 98,00 | 107,09 | 0,00 | 0,00 | |
| EBIT-Margin5 | 14,54 | 10,01 | 9,21 | 8,25 | 9,28 | 0,00 | 0,00 | |
| Net Profit (Loss)1 | 73,42 | 69,03 | 74,12 | 46,87 | 34,76 | 0,00 | 0,00 | |
| Net-Margin6 | 8,77 | 6,73 | 6,56 | 3,95 | 3,01 | 0,00 | 0,00 | |
| Cashflow1,7 | 149,93 | 165,27 | 145,03 | 179,53 | 128,88 | 0,00 | 0,00 | |
| Earnings per share8 | 1,40 | 1,30 | 1,40 | 0,88 | 0,66 | 1,07 | 1,22 | |
| Dividend per share8 | 0,50 | 0,50 | 0,50 | 1,00 | 0,05 | 0,50 | 0,50 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: KPMG
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| CompuGroup Medical | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| A28890 | DE000A288904 | SE & Co. KGaA | 1.450,83 Mio € | 04.05.2007 | Halten | 9F299HQG+3H |
| PE 2027e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 19,29 | 30,95 | 0,62 | 23,50 | 2,33 | 11,26 | 1,26 |
|
Dividend '2023 in € |
Dividend '2024 in € |
Dividend '2025e in € |
Div.-Yield '2025e in % |
| 1,00 | 0,05 | 0,50 | 1,85% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 17.04.2026 | 30.04.2025 | 31.07.2025 | 07.11.2024 | 06.03.2025 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| +0,57% | +8,74% | +5,97% | +20,21% | +50,00% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
